Kahira Pharmaceuticals & Chemical Industries Company (EGX: CPCI)

CPCI Cash Flow Statement

Financials in millions EGP. Fiscal year is July - June.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Mar 31, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020	Jun 30, 2019
Net Income	236.11	97.09	165.74	124.3	109.14	85.17
Depreciation & Amortization	40.82	17.86	-	-	0.65	-
Other Operating Activities	-82.7	-26.42	-113.92	37.95	-131.75	39.7
Operating Cash Flow	194.23	88.53	51.83	162.25	-21.96	124.87
Operating Cash Flow Growth	-	70.82%	-68.06%	-	-	196.48%
Capital Expenditures	-182.02	-79.07	-17.31	-23.68	-8.34	-11.47
Sale of Property, Plant & Equipment	0.63	0.08	0	0.04	-	0.24
Investment in Securities	-0.84	-	15.86	-14.11	14.47	-
Other Investing Activities	8.68	2.85	4.94	2.62	2.28	4.09
Investing Cash Flow	-173.54	-76.14	3.49	-35.13	8.41	-7.14
Long-Term Debt Issued	-	144.31	-	-	-	-
Long-Term Debt Repaid	-	-28.36	-	-	-	-
Net Debt Issued (Repaid)	110.89	115.95	-	-	-	-
Common Dividends Paid	-91.91	-100.82	-75.2	-77.73	-54.95	-60.92
Financing Cash Flow	18.98	15.13	-75.2	-77.73	-54.95	-60.92
Miscellaneous Cash Flow Adjustments	-0	-	-	-	-	-
Net Cash Flow	39.67	27.51	-19.89	49.39	-68.5	56.8
Free Cash Flow	12.21	9.45	34.52	138.57	-30.3	113.4
Free Cash Flow Growth	-	-72.61%	-75.09%	-	-	-
Free Cash Flow Margin	0.88%	0.94%	3.10%	13.05%	-3.00%	11.78%
Free Cash Flow Per Share	0.82	0.63	2.31	9.28	-2.03	7.59
Cash Income Tax Paid	41.12	73.12	51.33	36.22	36.35	56.55
Levered Free Cash Flow	80.24	71.41	-20.17	97.35	-51.72	88.38
Unlevered Free Cash Flow	90.62	73.59	-20.17	97.35	-51.72	88.38
Change in Net Working Capital	-50.76	-86.84	122.91	-23.32	130.76	-34.14

Source: S&P Capital IQ. Standard template. Financial Sources.